Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Number of employees : 71 000 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Pharmaceutical37,68988.8%41,75189.6% +10.78%
Animal Health4,2129.9%4,3939.4% +4.3%
Other143.000.3%521.001.1% +264.34%
Other Segment250.000.6%175.000.4% -30%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States18,21242.9%20,32543.6% +11.6%
Europe, Middle East and Africa12,21328.8%12,70727.3% +4.04%
Japan3,2127.6%3,5837.7% +11.55%
China2,1845.1%3,2076.9% +46.84%
Asia Pacific2,9096.9%2,9436.3% +1.17%
Latin America2,4155.7%2,4695.3% +2.24%
Other1,1492.7%1,6063.4% +39.77%
Managers
NameAgeSinceTitle
Kenneth Frazier642011Chairman, President & Chief Executive Officer
Robert M. Davis532016CFO & Executive Vice President-Global Services
Sandy Tremps-2016Vice President-R&D IT CIO
Thomas Henry Glocer592007Independent Director
Leslie Brun672014Lead Independent Director
Patricia Russo661995Independent Director
Peter C. Wendell682003Independent Director
Thomas Robert Cech, Dr.712009Independent Director
Pamela J. Craig622015Independent Director
Paul B. Rothman, Dr.612015Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,176,165 2,527,047,422 70.6% 1,047,935,095 29.3% 70.6%
Shareholders
NameEquities%
The Vanguard Group, Inc. 200,143,024 7.91%
Capital Research & Management Co. 138,704,087 5.48%
SSgA Funds Management, Inc. 118,791,132 4.70%
BlackRock Fund Advisors 63,751,213 2.52%
Wellington Management Co. LLP 42,335,445 1.67%
Geode Capital Management LLC 40,090,067 1.59%
Putnam LLC 36,951,155 1.46%
Capital Research & Management Co. (International Investors) 36,046,496 1.43%
Northern Trust Investments, Inc.(Investment Management) 33,760,704 1.33%
Capital Research & Management Co. (World Investors) 33,467,152 1.32%
Holdings
NameEquities%Valuation
NGM Biopharmaceuticals, Inc. (NGM) 12,955,01618.8%206,114,305 USD
Sutro Biopharma, Inc. (STRO) 2,723,5097.59%27,371,265 USD
4D pharma plc (DDDD) 7,661,0005.83%15,450,475 USD
KalVista Pharmaceuticals, Inc. (KALV) 1,070,5895.98%13,478,716 USD
OpGen, Inc. (OPGN) 10,8270.055%22,953 USD
Company contact information
Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth, NJ 07033

Phone : +1.908.740.4000
Web : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK & CO., INC.-12.23%201 909
JOHNSON & JOHNSON-0.43%382 391
ROCHE HOLDING AG-5.29%280 884
PFIZER INC.-2.55%212 162
NOVARTIS AG-16.78%185 999
NOVO NORDISK A/S15.16%164 690
ABBVIE INC.-4.74%148 846
ASTRAZENECA PLC4.42%135 994
BRISTOL-MYERS SQUIBB COMPANY-6.33%135 529
AMGEN INC.-5.77%133 046
ELI LILLY AND COMPANY8.33%129 063
SANOFI-7.45%123 347
GLAXOSMITHKLINE PLC-24.46%87 270
JIANGSU HENGRUI MEDICINE CO., LTD.20.86%69 658
CHUGAI PHARMACEUTICAL CO., LTD.27.41%67 163
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-19.21%52 214
DAIICHI SANKYO COMPANY, LIMITED11.40%49 803
BAYER AG-41.73%49 336
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED35.14%26 731
ASTELLAS PHARMA INC.-20.67%26 300